Navigation Links
UC San Diego to lead nationwide program in pharmacogenomics
Date:10/23/2008

The Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California, San Diego, will collaborate with the American Pharmacists Association, the American Society of Health-System Pharmacists, and the American Association of Colleges of Pharmacy to promote PharmGenEd, in an educational campaign to more than 100,000 pharmacy practitioners and students across the country.

The "Pharmacogenomics Education Program: Bridging the Gap between Science and Practice" (PharmGenEd) is designed to educate pharmacists, students and other healthcare professionals in pharmacogenomics, the study of individual genetic differences in response to drug therapy. The project has been funded for just over $1 million for three years by the Centers for Disease Control and Prevention (CDC.) The program team will work closely with the CDC to develop educational curriculum that focuses on basic pharmacogenomics concepts as well as their clinical applications, incorporating live and online methods including web-based virtual communities.

It is becoming increasingly clear that individuals respond differently to different medications, depending upon their genetic makeup, which impacts drug effectiveness and safety, as well as potential side effects. A key component of the program will "train the trainer" in methods to teach the next generation of pharmacists in this fast-moving field.

The program's principal investigator, Grace M. Kuo, PharmD, MPH, explains: "The field of genomics and its scientific discoveries are developing at a dazzling pace. Pharmacogenomics has a promising potential to increase the response rate of drug therapy and decrease the events of adverse drug reactions. It may help us focus on safe and effective drug management to provide personalized medicine by choosing the most appropriate therapy for a particular patient."

Currently, however, pharmacogenomics education materials are not readily available to healthcare professionals, and there appears to be a gap between healthcare providers' knowledge and the expectations of patients regarding pharmacogenomics testing.

A major aim of the program is to increase awareness of the use of pharmacogenomic testing and its potential implications. "Typing major genes affecting drug action has become cost effective and various genetic tests have been developed," said Kuo. "We will explore how these testing tools can be used to improve pharmacotherapy and prevent adverse drug outcomes in real practice, based on scientific evidence."

This project will also acquaint practitioners of pharmacy and medicine with sequence differences in the genome and how they may influence therapeutic outcomes. "The American Society of Health-System Pharmacists is pleased to support this important educational initiative," said Henri R. Manasse, Jr., Ph.D., Sc.D., the organization's CEO and executive vice president. "Pharmacists practicing in hospitals and health systems need to take a lead role in educating patients about what pharmacogenomics means for their individual therapy."

"Pharmacogenomics is all about tailoring drug therapy to genetic information," said Palmer Taylor, Ph.D., Dean of the Skaggs School and professor of pharmacology. "Recent research advances not only link genotypes to differences in drug metabolism and disposition in the body, but also to differences in responsiveness of the sites at which drugs act."


'/>"/>

Contact: Debra Kain
ddkain@ucsd.edu
619-543-6163
University of California - San Diego
Source:Eurekalert

Related medicine news :

1. TriWest On Deck to Support Fleet Week San Diego
2. In Celebration of Breast Cancer Awareness Month, Susan G. Komen for the Cure San Diego Announces Opportunities for San Diegans to Get Involved in the Fight Against Breast Cancer
3. San Diego Dentist Haunted by Smiles in Dominican Republic
4. UC San Diego researchers improve accuracy of breast cancer prognoses
5. Scripps Health Treats More Than 160 Fire Victims at Emergency Departments Across San Diego County
6. San Diego Wildfires Mental Health Fund
7. San Diegos SeQual Technologies Loans 35 Portable Oxygen Units to Evacuees at Qualcomm Stadium
8. Staying sharp in San Diego
9. St. Pauls Senior Homes & Services Welcomes Some of San Diegos Neediest Displaced Seniors
10. ASA San Diego Offers Resources and Information to Families with Autism in Wake of Fires
11. Announcing Always Best Care Senior Services Expansion Into San Diego, California
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... ... Paul Yost, will begin serving as new board chair for Orange County health ... will serve the remainder of soon-to-be former chair Mark Refowitz’s term, which runs ...
(Date:3/28/2017)... Appleton, WI (PRWEB) , ... March 28, 2017 ... ... how self-funded health plans work, the Self-Funding Success website has recently developed and ... about Self-Funded Health Plans ” was created based on common inquiries the site’s ...
(Date:3/28/2017)... ... March 28, 2017 , ... Prominant bariatric ... Inc. is thrilled to offer the recently FDA-approved Obalon Balloon System to his ... to SkyLex Advanced Surgical’s already comprehensive list of weight-loss services. Dr. Liu ...
(Date:3/28/2017)... Albertson, NY (PRWEB) , ... March 28, 2017 , ... Oily skin is a common ... with Advanced Dermatology has a lot to offer to the discussion of dealing ... good news is that there are many home remedies that can help remove the oily ...
(Date:3/27/2017)... ... March 27, 2017 , ... New patients who have sleep apnea ... with or without a referral. Sleep apnea is often left untreated because patients are ... headaches and chronic snoring. , Dr. Braasch seeks to raise awareness of sleep ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... , March 28, 2017  Akcea Therapeutics, a subsidiary ... to the company,s board of directors: ... Partners. Mr. Gabrieli will serve as chairman of the board ... former chief commercial officer of Forest Laboratories. ... Biolink Partners. "We are excited to ...
(Date:3/28/2017)... SAN FRANCISCO , March 28, 2017 ... is expected to reach USD 8.0 billion by 2025, ... Inc. The increasing incidence of infectious diseases and cancer ... for use in disease diagnosis over the coming years. ... the usage of autologous and allogenic stem cell therapy, ...
(Date:3/27/2017)... LONDON , March 27, 2017 ... require to better understand Eli Lilly and its partnering interests ... Alliance since 2010 report provides an in-depth insight into the ... companies. On demand company reports are prepared upon ... deal and company data. The report will be ...
Breaking Medicine Technology: